Irish biomaterials company sold to Ashland for $12m

Irish biomaterials company sold to Ashland for $12m
Sean McMahon

An Irish company that develops biomaterial solutions for the pharma and medical devices sector has been sold for $12 million to global chemical company Ashland.

Vornia produces a range of medical biomaterials for the pharmaceutical, cosmetic and medical devices industry, as well as for academic and industrial clients. Biomaterials are biological or synthetic substances which can be introduced into body tissue. Vornia’s biomaterial platform technologies can be applied in 3D bioprinting, drug and gene delivery and...

Subscribe from just 1€

Exclusive offers

Choose the subscription that is right for you

Monthly Subscription

€1

For the first month

€19.99 Monthly Thereafter

Subscribe today

Cancel anytime

Annual Subscription

€200€149

For the first year

€199.99 annually thereafter

Subscribe today

Cancel anytime

Quarterly Subscription

€55€42

For the first 90 days

€55.00 quarterly Thereafter

Subscribe today

Cancel anytime

These offers are not available for current subscribers. Offers and pricing are subject to change without notice.

Terms & Conditions Apply

Please Subscribe or Log in to continue

Subscribe Login

Related Articles

More from The Business Post